Plasma free iron and chemotherapy toxicity.
Beare
S
S
National Cancer Institute of Canada, Queen's University, Kingston, Ontario, Canada.
Steward
W P
WP
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D005609:Free Radicals; D006801:Humans; D007501:Iron / Q000097:blood*; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood* / Q000188:drug therapy*; D014168:Transferrin / Q000032:analysis
D000970:Antineoplastic Agents; D005609:Free Radicals; D007502:Iron Chelating Agents; D014168:Transferrin; D004317:Doxorubicin; D007501:Iron; D008727:Methotrexate